| |
| |
|
| Insider
Information: |
Payan Donald G |
| Relationship: |
EVP, Pres. Discovery&R... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
58,334 |
|
|
Indirect Shares
|
53,031 |
|
|
| Direct
Value |
$71,167 |
|
|
|
Indirect Value
|
$64,698 |
|
|
| Total
Shares |
111,365 |
|
|
| Total
Value |
$135,865 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Rigel Pharmaceuticals Inc |
RIGL |
EVP, Pres. Discovery&R... |
2015-06-10 |
58,334 |
2016-08-30 |
53,031 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RIGL |
Rigel Pharmaceuticals Inc |
EVP, Pres. Discovery&Research |
• • – |
2016-08-30 |
4 |
AS |
$4.00 |
$21,214 |
I/I |
(5,303) |
53,031 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP, Pres. Discovery&Research |
• • – |
2015-06-10 |
4 |
OE |
$2.14 |
$89,165 |
D/D |
41,666 |
100,000 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP, Pres. Discovery&Research |
• • – |
2015-06-10 |
4 |
S |
$3.68 |
$153,214 |
D/D |
(41,666) |
58,334 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP, Pres. Discovery&Research |
• • – |
2015-04-01 |
4 |
S |
$3.75 |
$37,518 |
D/D |
(10,000) |
58,334 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP, Pres. Discovery&Research |
• • – |
2014-09-03 |
4 |
S |
$2.56 |
$51,200 |
D/D |
(20,000) |
68,334 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP, Pres. Discovery&Research |
• • – |
2014-02-24 |
4 |
S |
$3.71 |
$74,238 |
D/D |
(20,000) |
88,334 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP, Pres. Discovery&Research |
• • – |
2012-06-19 |
4 |
S |
$8.70 |
$87,008 |
D/D |
(10,000) |
108,334 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
EVP, Pres. Discovery&Research |
• • – |
2009-01-02 |
4 |
OE |
$1.80 |
$6,001 |
D/D |
3,334 |
118,334 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Ex. VP. Chief Sci. Officer |
• • – |
2003-07-31 |
4 |
OE |
$5.76 |
$94,222 |
D/D |
16,358 |
115,000 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
